​

Vigil Neuroscience (VIGL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

VIGL Stock Forecast

Vigil Neuroscience (VIGL) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $8.00, with a high of $8.00 and a low of $8.00. This represents a -0.62% decline from the last price of $8.05.

$1 $2 $3 $4 $5 $6 $7 $8 $9 High: $8 Avg: $8 Low: $8 Last Closed Price: $8.05

VIGL Stock Rating

Vigil Neuroscience stock's rating consensus is Hold, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (14.29%), 5 Hold (71.43%), 1 Sell (14.29%), and 0 Strong Sell (0.00%).

Hold
Total 7 0 1 5 1 Strong Sell Sell Hold Buy Strong Buy

VIGL Price Target Upside V Benchmarks

TypeNameUpside
StockVigil Neuroscience-0.62%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$8.00
Last Closing Price$8.05$8.05$8.05
Upside/Downside---0.62%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Aug, 25--8--8
Jul, 25--8--8
Jun, 25--8--8
May, 2526---8
Apr, 2526---8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 22, 2025Yatin SunejaGuggenheim$8.00$7.881.52%-0.62%
Aug 15, 2024Paul MatteisStifel Nicolaus$11.00$3.12252.56%36.65%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 27, 2025H.C. WainwrightBuyNeutraldowngrade
May 22, 2025JefferiesHolddowngrade
May 22, 2025WedbushOutperformNeutraldowngrade
May 22, 2025GuggenheimBuyNeutraldowngrade
May 22, 2025William BlairMarket Performdowngrade
May 22, 2025CitigroupMarket Performdowngrade
Aug 14, 2024GuggenheimBuyBuyhold
Jun 28, 2024WedbushOutperformOutperformhold
Jun 28, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.13$-2.07----
Avg Forecast$-2.09$-2.04$-1.86$-1.65$-1.36$0.58
High Forecast$-1.99$-1.94$-1.61$-0.52$0.32$0.58
Low Forecast$-2.18$-2.15$-2.11$-2.60$-2.67$0.58
Surprise %1.91%1.47%----

Revenue Forecast

$0 $60M $120M $180M $240M $300M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$287.50K$17.56M$96.83M$274.64M
High Forecast--$287.50K$17.56M$96.83M$274.64M
Low Forecast--$287.50K$17.56M$96.83M$274.64M
Surprise %------

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-82.64M$-84.26M----
Avg Forecast$-82.64M$-82.60M$-71.94M$-60.37M$-99.51M$22.36M
High Forecast$-76.85M$-75.04M$-62.37M$-20.12M$12.39M$22.36M
Low Forecast$-84.49M$-83.42M$-81.51M$-100.62M$-103.36M$22.36M
Surprise %-2.01%----

VIGL Forecast FAQ

Is Vigil Neuroscience stock a buy?

Vigil Neuroscience stock has a consensus rating of Hold, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 5 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Vigil Neuroscience is a neutral investment for most analysts.

What is Vigil Neuroscience's price target?

Vigil Neuroscience's price target, set by 7 Wall Street analysts, averages $8 over the next 12 months. The price target range spans from $8 at the low end to $8 at the high end, suggesting a potential -0.62% change from the previous closing price of $8.05.

How does Vigil Neuroscience stock forecast compare to its benchmarks?

Vigil Neuroscience's stock forecast shows a -0.62% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Vigil Neuroscience over the past three months?

  • August 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • July 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • June 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Vigil Neuroscience’s EPS forecast?

Vigil Neuroscience's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.86, marking a -10.14% decrease from the reported $-2.07 in 2024. Estimates for the following years are $-1.65 in 2026, $-1.36 in 2027, and $0.58 in 2028.

What is Vigil Neuroscience’s revenue forecast?

Vigil Neuroscience's average annual revenue forecast for its fiscal year ending in December 2025 is $287.5K, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $17.56M, followed by $96.83M for 2027, and $274.64M for 2028.

What is Vigil Neuroscience’s net income forecast?

Vigil Neuroscience's net income forecast for the fiscal year ending in December 2025 stands at $-71.94M, representing a -14.62% decrease from the reported $-84.256M in 2024. Projections indicate $-60.37M in 2026, $-99.508M in 2027, and $22.36M in 2028.